Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
Clinical trial NCT04370483 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04370483
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2026-11-10
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.